Phenotyping the Prediabetic Population-A Closer Look at Intermediate Glucose Status and Cardiovascular Disease

Elena Barbu1, Mihaela-Roxana Popescu1, Andreea-Catarina Popescu1

  • 1Department of Cardiology, Elias Emergency University Hospital, Carol Davila University of Medicine and Pharmacy, 011461 Bucharest, Romania.

Insights

Prediabetes characterization remains controversial despite updated thresholds. Identifying high-risk individuals for cardiovascular disease and closer monitoring is crucial for effective prevention and management.

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Cardiovascular Disease

Background:

  • The definition of prediabetes lacks precise characterization, despite its known risks for diabetes and vascular complications.
  • The current rigid definition overlooks pathophysiological mechanisms and progression towards overt diabetes.
  • Inflammation is a common factor in risk factors associated with prediabetes, worsening prognosis.

Purpose of the Study:

  • To review screening criteria for prediabetes.
  • To identify prediabetic patients at higher risk for cardiovascular disease (CVD).
  • To emphasize the need for closer monitoring in high-risk prediabetic individuals.

Main Methods:

  • Literature review focusing on prediabetes definition and risk stratification.
  • Analysis of pathophysiological mechanisms linking prediabetes to CVD.
  • Identification of inflammatory markers and risk factors.

Main Results:

  • The prediabetic population is heterogeneous, necessitating refined phenotyping for risk assessment.
  • Current definitions do not adequately capture the spectrum of metabolic dysfunction.
  • Inflammation is a key driver of CVD risk in prediabetes.

Conclusions:

  • Refined phenotyping of prediabetes is essential for personalized risk assessment and prevention strategies.
  • Targeted screening and closer monitoring are required for prediabetic individuals at high CVD risk.
  • Understanding the role of inflammation is critical for managing prediabetes and preventing complications.

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.4K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.6K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.2K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.1K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
371
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.8K